A Randomized Phase 1 Study Evaluating Pharmacokinetics, Safety, and Tolerability of a High-Concentration, Long-Acting Cabotegravir Formulation in Adults Without HIV
一项随机 I 期研究，旨在评估高浓度长效卡博特韦制剂在非 HIV 感染成人中的药代动力学、安全性和耐受性。
期刊:Clinical Pharmacology in Drug Development
影响因子:
doi:10.1002/cpdd.1538
Han, Kelong; Benn, Paul; Sievers, Jörg; Dorey, David; Warwick-Sanders, Michael; Hareedy, Randa; Harkness, Louise; Leemereise, Claudia; Offenbecker, Kjersten; Donatti, Christina; Brimhall, Darin B; Schwabe, Christian; Boyle, Craig; Hassman, Michael A; Knowles, Steve; D'Amico, Ronald; Spreen, William R
